302 related articles for article (PubMed ID: 36917260)
41. Screen-detected versus interval cancers: Effect of imaging modality and breast density in the Flemish Breast Cancer Screening Programme.
Timmermans L; Bleyen L; Bacher K; Van Herck K; Lemmens K; Van Ongeval C; Van Steen A; Martens P; De Brabander I; Goossens M; Thierens H
Eur Radiol; 2017 Sep; 27(9):3810-3819. PubMed ID: 28289944
[TBL] [Abstract][Full Text] [Related]
42. Stand-Alone Use of Artificial Intelligence for Digital Mammography and Digital Breast Tomosynthesis Screening: A Retrospective Evaluation.
Romero-Martín S; Elías-Cabot E; Raya-Povedano JL; Gubern-Mérida A; Rodríguez-Ruiz A; Álvarez-Benito M
Radiology; 2022 Mar; 302(3):535-542. PubMed ID: 34904872
[TBL] [Abstract][Full Text] [Related]
43. Mammographic density and interval cancers in mammographic screening: Moving towards more personalized screening.
Larsen M; Lynge E; Lee CI; Lång K; Hofvind S
Breast; 2023 Jun; 69():306-311. PubMed ID: 36966656
[TBL] [Abstract][Full Text] [Related]
44. Women's attitudes and perspectives on the use of artificial intelligence in the assessment of screening mammograms.
Holen ÅS; Martiniussen MA; Bergan MB; Moshina N; Hovda T; Hofvind S
Eur J Radiol; 2024 Jun; 175():111431. PubMed ID: 38520804
[TBL] [Abstract][Full Text] [Related]
45. Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial.
Hofvind S; Holen ÅS; Aase HS; Houssami N; Sebuødegård S; Moger TA; Haldorsen IS; Akslen LA
Lancet Oncol; 2019 Jun; 20(6):795-805. PubMed ID: 31078459
[TBL] [Abstract][Full Text] [Related]
46. Screening outcome for interpretation by the first and second reader in a population-based mammographic screening program with independent double reading.
Hovda T; Sagstad S; Larsen M; Chen Y; Hofvind S
Acta Radiol; 2023 Aug; 64(8):2371-2378. PubMed ID: 37246466
[TBL] [Abstract][Full Text] [Related]
47. Derived mammographic masking measures based on simulated lesions predict the risk of interval cancer after controlling for known risk factors: a case-case analysis.
Hinton B; Ma L; Mahmoudzadeh AP; Malkov S; Fan B; Greenwood H; Joe B; Lee V; Strand F; Kerlikowske K; Shepherd J
Med Phys; 2019 Mar; 46(3):1309-1316. PubMed ID: 30697755
[TBL] [Abstract][Full Text] [Related]
48. AI-based prevention of interval cancers in a national mammography screening program.
Byng D; Strauch B; Gnas L; Leibig C; Stephan O; Bunk S; Hecht G
Eur J Radiol; 2022 Jul; 152():110321. PubMed ID: 35512511
[TBL] [Abstract][Full Text] [Related]
49. Early Indicators of the Impact of Using AI in Mammography Screening for Breast Cancer.
Lauritzen AD; Lillholm M; Lynge E; Nielsen M; Karssemeijer N; Vejborg I
Radiology; 2024 Jun; 311(3):e232479. PubMed ID: 38832880
[TBL] [Abstract][Full Text] [Related]
50. Use of Artificial Intelligence for Reducing Unnecessary Recalls at Screening Mammography: A Simulation Study.
Kim YS; Jang MJ; Lee SH; Kim SY; Ha SM; Kwon BR; Moon WK; Chang JM
Korean J Radiol; 2022 Dec; 23(12):1241-1250. PubMed ID: 36447412
[TBL] [Abstract][Full Text] [Related]
51. Changes in cancer detection and false-positive recall in mammography using artificial intelligence: a retrospective, multireader study.
Kim HE; Kim HH; Han BK; Kim KH; Han K; Nam H; Lee EH; Kim EK
Lancet Digit Health; 2020 Mar; 2(3):e138-e148. PubMed ID: 33334578
[TBL] [Abstract][Full Text] [Related]
52. Tumour characteristics of screen-detected and interval cancers in the Flemish Breast Cancer Screening Programme: A mammographic breast density study.
Timmermans L; De Brabander I; Van Damme N; Bleyen L; Martens P; Van Herck K; Thierens H; Bacher K; Depypere H
Maturitas; 2022 Apr; 158():55-60. PubMed ID: 35241239
[TBL] [Abstract][Full Text] [Related]
53. External Evaluation of 3 Commercial Artificial Intelligence Algorithms for Independent Assessment of Screening Mammograms.
Salim M; Wåhlin E; Dembrower K; Azavedo E; Foukakis T; Liu Y; Smith K; Eklund M; Strand F
JAMA Oncol; 2020 Oct; 6(10):1581-1588. PubMed ID: 32852536
[TBL] [Abstract][Full Text] [Related]
54. One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): a prospective, population-based, diagnostic accuracy study.
Zackrisson S; Lång K; Rosso A; Johnson K; Dustler M; Förnvik D; Förnvik H; Sartor H; Timberg P; Tingberg A; Andersson I
Lancet Oncol; 2018 Nov; 19(11):1493-1503. PubMed ID: 30322817
[TBL] [Abstract][Full Text] [Related]
55. Depiction of breast cancers on digital mammograms by artificial intelligence-based computer-assisted diagnosis according to cancer characteristics.
Lee SE; Han K; Yoon JH; Youk JH; Kim EK
Eur Radiol; 2022 Nov; 32(11):7400-7408. PubMed ID: 35499564
[TBL] [Abstract][Full Text] [Related]
56. Use of an AI Score Combining Cancer Signs, Masking, and Risk to Select Patients for Supplemental Breast Cancer Screening.
Liu Y; Sorkhei M; Dembrower K; Azizpour H; Strand F; Smith K
Radiology; 2024 Apr; 311(1):e232535. PubMed ID: 38591971
[TBL] [Abstract][Full Text] [Related]
57. Norwegian radiologists' expectations of artificial intelligence in mammographic screening - A cross-sectional survey.
Martiniussen MA; Larsen M; Larsen ASF; Hovda T; Koch HW; Bjørnerud A; Hofvind S
Eur J Radiol; 2023 Oct; 167():111061. PubMed ID: 37657381
[TBL] [Abstract][Full Text] [Related]
58. Risk factors and tumor characteristics of interval cancers by mammographic density.
Holm J; Humphreys K; Li J; Ploner A; Cheddad A; Eriksson M; Törnberg S; Hall P; Czene K
J Clin Oncol; 2015 Mar; 33(9):1030-7. PubMed ID: 25646195
[TBL] [Abstract][Full Text] [Related]
59. Screening outcome for consecutive examinations with digital breast tomosynthesis versus standard digital mammography in a population-based screening program.
Hovda T; Brandal SHB; Sebuødegård S; Holen ÅS; Bjørndal H; Skaane P; Hofvind S
Eur Radiol; 2019 Dec; 29(12):6991-6999. PubMed ID: 31187221
[TBL] [Abstract][Full Text] [Related]
60. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers.
Mandelson MT; Oestreicher N; Porter PL; White D; Finder CA; Taplin SH; White E
J Natl Cancer Inst; 2000 Jul; 92(13):1081-7. PubMed ID: 10880551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
